Gene · 81608
Papers2,072
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,072
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Irregular antibodies in pregnancy during the universal anti-RHD prophylaxis era: a survey of Spanish Hospitals. | Blood Transfus | 2026 | 41701898 | PubTator, text mining | PubMed |
| Recurrent Orogenital Ulcers: A Rare Case of Myeloid Neoplasm Associated with FIP1L1-PDGFRA Rearrangement with Rapid Response to Imatinib. | Indian Dermatol Online J | 2026 | 41668313 | PubTator, text mining | PubMed |
| Myeloid neoplasm with eosinophilia associated with FIP1L1-PDGFRA presenting as femoral avascular necrosis: a rare case report. | Hematol Transfus Cell Ther | 2026 | 41655321 | PubTator, text mining | PubMed |
| Direct coupling of the human nuclear exosome adaptors NEXT and PAXT with transcription termination and processing machineries. | Nucleic Acids Res | 2026 | 41641703 | PubTator, text mining | PubMed |
| Harnessing AACR Project GENIE to Define the Molecular Features of Desmoplastic Small Round Cell Tumor. | Curr Issues Mol Biol | 2026 | 41614915 | PubTator, text mining | PubMed |
| First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents. | J Med Chem | 2026 | 41587275 | PubTator, text mining | PubMed |
| Ulcers and Eosinophils: A Rare Presentation of PDGFRA-Rearranged Myeloid Neoplasm Responding to Imatinib. | J Investig Med High Impact Case Rep | 2026 | 41532370 | PubTator, text mining | PubMed |
| A rare case of variant acute promyelocytic leukemia with FIP1L1-RARA fusion gene: case report and literature review. | Leuk Res Rep | 2026 | 41426279 | PubTator, text mining | PubMed |
| From bone marrow to the heart: a case report of cardiac involvement in myeloproliferative-associated hypereosinophilic syndrome. | Future Cardiol | 2026 | 41403213 | PubTator, text mining | PubMed |
| Leveraging ancestral recombination graphs for scalable mixed-model analysis of complex traits. | Cell Genom | 2026 | 41380687 | PubTator, text mining | PubMed |
| Loeffler Syndrome in FIP1L1-PDGFRA-Positive Myeloid Neoplasm. | JACC Case Rep | 2026 | 41379052 | PubTator, text mining | PubMed |
| Imatinib Treatment in Primary Acute Basophilic Leukemia with FIP1L1-PDGFRα Rearrangement: A Case Report. | Acta Haematol | 2026 | 41237070 | PubTator, text mining | PubMed |
| Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvement. | Leuk Lymphoma | 2026 | 41194520 | PubTator, text mining | PubMed |
| Fulminant Idiopathic Hypereosinophilic Syndrome Presenting with Cardiac, Neurologic and Haematologic Involvement. | Eur J Case Rep Intern Med | 2025 | 41536447 | PubTator, text mining | PubMed |
| Evaluation and differential diagnosis of eosinophilia: A tertiary allergy center experience. | Tuberk Toraks | 2025 | 41486796 | PubTator, text mining | PubMed |
| The Role of mRNA Alternative Processing in Mammalian Neurodevelopment. | Int J Mol Sci | 2025 | 41303558 | PubTator, text mining | PubMed |
| Novel BMP2K::PDGFRA fusion in an unusual myeloid/lymphoid neoplasm with eosinophilia. | J Hematop | 2025 | 41131416 | PubTator, text mining | PubMed |
| Analytical and computational solution for the estimation of SNP-heritability in biobank-scale and distributed datasets. | PLoS Comput Biol | 2025 | 41118419 | PubTator, text mining | PubMed |
| Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome. | J Allergy Clin Immunol Pract | 2025 | 40992688 | PubTator, text mining | PubMed |
| Maintenance of neuronal TDP-43 expression requires axonal lysosome transport. | Elife | 2025 | 40970386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81608/papers?page=2